Updated:
Globus Medical
Globus Medical is a asset manager based in Audubon; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
Globus Medical
Globus Medical develops musculoskeletal device solutions. The company manufactures and distributes these devices. It produces implants and products.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Audubon
Corporate office
Audubon, PA, United States
Additional offices
San Diego, CA, United States · Methuen, MA, United States · Memphis, TN, United States · Seven Hills, Australia · Barueri, Brazil · Bremen, Germany · Kowloon Bay, Hong Kong · Milan, Italy · Tokyo, Japan · Brunssum, Netherlands · Amstelveen, Netherlands · Singapore · Johannesburg, South Africa · Risch Rotkreuz, Switzerland · Northampton, United Kingdom · San Antonio, TX, United States · Limerick, PA, United States · Columbia, MD, United States · West Carrollton, OH, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Globus Medical?
Investment decisions at Globus Medical are made by its executive leadership and board of directors, not by a single family office or founding family. The CEO as of 2025 is Dan Scavilla, who leads strategy alongside the executive team. The company is publicly traded on the NYSE (GMED) and subject to shareholder oversight.
How does Globus Medical source proprietary technology?
Globus Medical operates an internal rapid design-prototype-test cycle using its own fabrication and testing facilities in Pennsylvania. The product development teams work directly from surgeon feedback to identify unmet clinical needs. This vertical integration allows the firm to control intellectual property and manufacturing in-house rather than relying on external contract manufacturers.
Is Globus Medical structured as a family office?
No, Globus Medical is a publicly traded corporation (NYSE: GMED). It does not operate as a family office or asset manager. The firm functions as a medical device manufacturer with a market capitalization of roughly $8B as of early 2025.
What investment stages does Globus Medical target?
Globus Medical does not make external investments; it allocates capital internally toward R&D, manufacturing capacity, and strategic acquisitions. The firm executed a major acquisition of NuVasive in 2024 for $3.1B. Acquisitions serve to expand its product portfolio across spine, orthopedic, and enabling technologies.
Which sectors does Globus Medical focus on?
Globus Medical focuses exclusively on musculoskeletal technology, including spinal implants and instruments, orthopedic trauma and joint reconstruction products, regenerative biologics, and surgical robotics and navigation systems (Excelsius platform). The firm explicitly avoids unrelated industries.
Where does the underlying wealth come from?
Globus Medical is a public company and does not generate wealth for a single family. Its revenue comes from sales of medical devices and surgical technologies to hospitals and healthcare providers globally. The firm reported $2.5B in revenue in 2024 (per SEC filing).
Does Globus Medical maintain philanthropic structures?
Globus Medical operates the Musculoskeletal Education and Research Center (MERC) which provides surgeon education and supports clinical research. MERC partners with surgeon faculty to offer cadaveric labs, didactic sessions, and peer-to-peer training programs. The firm does not disclose a separate charitable foundation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: